Insulin transcriptionally regulates argininosuccinate synthase to maintain vascular endothelial function

Biochemical and Biophysical Research Communications

Volumn 421, Issue 1, 2012, Pages 9-14

  Haines, Ricci J ^a   Corbin, Karen D ^b   Pendleton, Laura C ^a   Meininger, Cynthia J ^c   Eichler, Duane C ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

AS; ENOS; Insulin; Streptozotocin; Vasorelaxation

Indexed keywords

ARGININOSUCCINATE SYNTHASE; BRADYKININ; CITRULLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INSULIN; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME REGULATION; INSULIN METABOLISM; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; ANIMALS; ARGININOSUCCINATE SYNTHASE; CATTLE; CELL LINE; CORONARY VESSELS; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; INSULIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; RATS; TRANSCRIPTION, GENETIC; VASODILATION;

ANIMALIA; RATTUS;

EID: 84860322014     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.03.074     Document Type: Article

References (39)

1. Potenza M.A., Gagliardi S., Nacci C., Carratu M.R., Montagnani M. Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Curr. Med. Chem. 2009, 16:94-112.
2. Flam B.R., Eichler D.C., Solomonson L.P. Endothelial nitric oxide production is tightly coupled to the citrulline-NO cycle. Nitric Oxide 2007, 17:115-121.
3. Erez A., Nagamani S.C., Shchelochkov O.A., Premkumar M.H., Campeau P.M., Chen Y., Garg H.K., Li L., Mian A., Bertin T.K., Black J.O., Zeng H., Tang Y., Reddy A.K., Summar M., O'Brien W.E., Harrison D.G., Mitch W.E., Marini J.C., Aschner J.L., Bryan N.S. B. Lee, Requirement of argininosuccinate lyase for systemic nitric oxide production. Nat. Med. 2011, 17:1619-1626.
4. Mun G.I., Kim I.S., Lee B.H., Boo Y.C. Endothelial argininosuccinate synthetase 1 regulates nitric oxide production and monocyte adhesion under static and laminar shear stress conditions. J. Biol. Chem. 2011, 286:2536-2542.
5. Goodwin B., Pendleton L., Levy M., Solomonson L., Eichler D. Tumor necrosis factor-{alpha} reduces substrate availability for nitric oxide production via down-regulation of argininosuccinate synthase. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H1115-H1121.
6. Goodwin B.L., Solomonson L.P., Eichler D.C. Argininosuccinate synthase expression is required to maintain nitric oxide production and cell viability in aortic endothelial cells. J. Biol. Chem. 2004, 279:18353-18360.
7. Harris M.B., Ju H., Venema V.J., Liang H., Zou R., Michell B.J., Chen Z.P., Kemp B.E., Venema R.C. Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation. J. Biol. Chem. 2001, 276:16587-16591.
8. Zecchin H.G., Priviero F.B., Souza C.T., Zecchin K.G., Prada P.O., Carvalheira J.B., Velloso L.A., Antunes E., Saad M.J. Defective insulin and acetylcholine induction of endothelial cell-nitric oxide synthase through insulin receptor substrate/Akt signaling pathway in aorta of obese rats. Diabetes 2007, 56:1014-1024.
9. Kuboki K., Jiang Z.Y., Takahara N., Ha S.W., Igarashi M., Yamauchi T., Feener E.P., Herbert T.P., Rhodes C.J., King G.L. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation 2000, 101:676-681.
10. 2+ but requires phosphorylation by Akt at Ser(1179). J. Biol. Chem. 2001, 276:30392-30398.
11. Petrie J.R., Ueda S., Webb D.J., Elliott H.L., Connell J.M. Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease. Circulation 1996, 93:1331-1333.
12. Baron A.D., Brechtel G., Johnson A., Fineberg N., Henry D.P., Steinberg H.O. Interactions between insulin and norepinephrine on blood pressure and insulin sensitivity. Studies in lean and obese men. J. Clin. Invest. 1994, 93:2453-2462.
13. Vollenweider P., Randin D., Tappy L., Jequier E., Nicod P., Scherrer U. Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J. Clin. Invest. 1994, 93:2365-2371.
14. McVeigh G.E., Brennan G.M., Johnston G.D., McDermott B.J., McGrath L.T., Henry W.R., Andrews J.W., Hayes J.R. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992, 35:771-776.
15. Martinez-Nieves B., Dunbar J.C. Vascular dilatatory responses to sodium nitroprusside (SNP) and alpha-adrenergic antagonism in female and male normal and diabetic rats. Proc. Soc. Exp. Biol. Med. 1999, 222:90-98.
16. Napoli C., Ignarro L.J. Nitric oxide and atherosclerosis. Nitric Oxide 2001, 5:88-97.
17. Honing M.L., Morrison P.J., Banga J.D., Stroes E.S., Rabelink T.J. Nitric oxide availability in diabetes mellitus. Diabetes Metab. Rev. 1998, 14:241-249.
18. Stump C.S., Short K.R., Bigelow M.L., Schimke J.M., Nair K.S. Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proc. Natl. Acad. Sci. USA 2003, 100:7996-8001.
19. Sechi L.A., Melis A., Tedde R. Insulin hypersecretion: a distinctive feature between essential and secondary hypertension. Metabolism 1992, 41:1261-1266.
20. Oyadomari S., Gotoh T., Aoyagi K., Araki E., Shichiri M., Mori M. Coinduction of endothelial nitric oxide synthase and arginine recycling enzymes in aorta of diabetic rats. Nitric Oxide 2001, 5:252-260.
21. B.L. Goodwin, L.C. Pendleton, M.M. Levy, L.P. Solomonson, D.C. Eichler, Selective PPARc agonists promote vascular endothelial NO production through the up-regulation of argininosuccinate synthase, Mol. Endocrinol., submitted for publication.
22. Goodwin B.L., Corbin K.D., Pendleton L.C., Levy M.M., Solomonson L.P., Eichler D.C. Troglitazone up-regulates vascular endothelial argininosuccinate synthase. Biochem. Biophys. Res. Commun. 2008, 370:254-258.
23. Zuidema M.Y., Yang Y., Wang M., Kalogeris T., Liu Y., Meininger C.J., Hill M.A., Davis M.J., Korthuis R.J. Antecedent hydrogen sulfide elicits an anti-inflammatory phenotype in postischemic murine small intestine: role of BK channels. Am. J. Physiol. Heart Circ. Physiol. 2010, 299:H1554-H1567.
24. Kleinhenz D.J., Fan X., Rubin J., Hart C.M. Detection of endothelial nitric oxide release with the 2,3-diaminonapthalene assay. Free Radic. Biol. Med. 2003, 34:856-861.
25. Pendleton L.C., Goodwin B.L., Flam B.R., Solomonson L.P., Eichler D.C. Endothelial argininosuccinate synthase mRNA 5'-untranslated region diversity. Infrastructure for tissue-specific expression. J. Biol. Chem. 2002, 277:25363-25369.
26. Griffin K.L., Laughlin M.H., Parker J.L. Exercise training improves endothelium-mediated vasorelaxation after chronic coronary occlusion. J. Appl. Physiol. 1999, 87:1948-1956.
27. Xie L., Hattori Y., Tume N., Gross S.S. The preferred source of arginine for high-output nitric oxide synthesis in blood vessels. Semin. Perinatol. 2000, 24:42-45.
28. Xie L., Gross S.S. Argininosuccinate synthetase overexpression in vascular smooth muscle cells potentiates immunostimulant-induced NO production. J. Biol. Chem. 1997, 272:16624-16630.
29. Flam B.R., Hartmann P.J., Harrell-Booth M., Solomonson L.P., Eichler D.C. Caveolar localization of arginine regeneration enzymes, argininosuccinate synthase, and lyase, with endothelial nitric oxide synthase. Nitric Oxide 2001, 5:187-197.
30. Ritchie S.A., Kohlhaas C.F., Boyd A.R., Yalla K.C., Walsh K., Connell J.M., Salt I.P. Insulin-stimulated phosphorylation of endothelial nitric oxide synthase at serine-615 contributes to nitric oxide synthesis. Biochem. J. 2010, 426:85-90.
31. Wang H., Wang A.X., Liu Z., Chai W., Barrett E.J. The trafficking/interaction of eNOS and caveolin-1 induced by insulin modulates endothelial nitric oxide production. Mol. Endocrinol. 2009, 23:1613-1623.
32. Potenza M.A., Addabbo F., Montagnani M. Vascular actions of insulin with implications for endothelial dysfunction. Am. J. Physiol. Endocrinol. Metab. 2009, 297:E568-E577.
33. Fisslthaler B., Benzing T., Busse R., Fleming I. Insulin enhances the expression of the endothelial nitric oxide synthase in native endothelial cells: a dual role for Akt and AP-1. Nitric Oxide 2003, 8:253-261.
34. Brosnan J.T., Man K.C., Hall D.E., Colbourne S.A., Brosnan M.E. Interorgan metabolism of amino acids in streptozotocin-diabetic ketoacidotic rat. Am. J. Physiol. 1983, 244:E151-E158.
35. Wu G., Meininger C.J. Impaired arginine metabolism and NO synthesis in coronary endothelial cells of the spontaneously diabetic BB rat. Am. J. Physiol. 1995, 269:H1312-H1318.
36. Pieper G.M. Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction. Hypertension 1998, 31:1047-1060.
37. Like A.A., Rossini A.A. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 1976, 193:415-417.
38. Meininger C.J., Cai S., Parker J.L., Channon K.M., Kelly K.A., Becker E.J., Wood M.K., Wade L.A., Wu G. GTP cyclohydrolase I gene transfer reverses tetrahydrobiopterin deficiency and increases nitric oxide synthesis in endothelial cells and isolated vessels from diabetic rats. FASEB J. 2004, 18:1900-1902.
39. Huk I., Nanobashvili J., Neumayer C., Punz A., Mueller M., Afkhampour K., Mittlboeck M., Losert U., Polterauer P., Roth E., Patton S., Malinski T. l-Arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle. Circulation 1997, 96:667-675.